412 related articles for article (PubMed ID: 17319461)
1. Leptin and hypertension in obesity.
Bravo PE; Morse S; Borne DM; Aguilar EA; Reisin E
Vasc Health Risk Manag; 2006; 2(2):163-9. PubMed ID: 17319461
[TBL] [Abstract][Full Text] [Related]
2. Role of sympathetic nervous system and neuropeptides in obesity hypertension.
Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S
Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088
[TBL] [Abstract][Full Text] [Related]
3. Interaction between leptin and sympathetic nervous system in hypertension.
Haynes WG
Curr Hypertens Rep; 2000 Jun; 2(3):311-8. PubMed ID: 10981165
[TBL] [Abstract][Full Text] [Related]
4. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
[TBL] [Abstract][Full Text] [Related]
5. Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension.
Engeli S; Sharma AM
Curr Opin Cardiol; 2002 Jul; 17(4):355-9. PubMed ID: 12151869
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of obesity hypertension.
Hall JE
Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140
[TBL] [Abstract][Full Text] [Related]
7. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.
Kalil GZ; Haynes WG
Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570
[TBL] [Abstract][Full Text] [Related]
8. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications.
Mark AL; Correia ML; Rahmouni K; Haynes WG
J Hypertens; 2002 Jul; 20(7):1245-50. PubMed ID: 12131511
[TBL] [Abstract][Full Text] [Related]
9. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).
Landsberg L
J Hypertens; 2001 Mar; 19(3 Pt 2):523-8. PubMed ID: 11327624
[TBL] [Abstract][Full Text] [Related]
10. Factors that influence the risk of hypertension in obese individuals.
Coatmellec-Taglioni G; Ribière C
Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070
[TBL] [Abstract][Full Text] [Related]
11. Experimental hyperleptinemia acutely increases vasoconstrictory sympathetic nerve activity in healthy humans.
Machleidt F; Simon P; Krapalis AF; Hallschmid M; Lehnert H; Sayk F
J Clin Endocrinol Metab; 2013 Mar; 98(3):E491-6. PubMed ID: 23393176
[TBL] [Abstract][Full Text] [Related]
12. Obesity hypertension: role of leptin and sympathetic nervous system.
Hall JE; Hildebrandt DA; Kuo J
Am J Hypertens; 2001 Jun; 14(6 Pt 2):103S-115S. PubMed ID: 11411745
[TBL] [Abstract][Full Text] [Related]
13. Role of leptin and central nervous system melanocortins in obesity hypertension.
da Silva AA; do Carmo JM; Hall JE
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):135-40. PubMed ID: 23299052
[TBL] [Abstract][Full Text] [Related]
14. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Obesity: a common prime mover of chronic activation of the sympathetic nervous system and the renin-angiotensin system in systemic hypertension?
Szelényi Z
J Appl Physiol (1985); 2010 Dec; 109(6):2008-9. PubMed ID: 21188835
[No Abstract] [Full Text] [Related]
15. Mechanisms of obesity-induced hypertension.
Kotsis V; Stabouli S; Papakatsika S; Rizos Z; Parati G
Hypertens Res; 2010 May; 33(5):386-93. PubMed ID: 20442753
[TBL] [Abstract][Full Text] [Related]
16. The kidney, hypertension, and obesity.
Hall JE
Hypertension; 2003 Mar; 41(3 Pt 2):625-33. PubMed ID: 12623970
[TBL] [Abstract][Full Text] [Related]
17. Obesity-associated hypertension: new insights into mechanisms.
Rahmouni K; Correia ML; Haynes WG; Mark AL
Hypertension; 2005 Jan; 45(1):9-14. PubMed ID: 15583075
[TBL] [Abstract][Full Text] [Related]
18. Rapid onset of renal sympathetic nerve activation in rabbits fed a high-fat diet.
Armitage JA; Burke SL; Prior LJ; Barzel B; Eikelis N; Lim K; Head GA
Hypertension; 2012 Jul; 60(1):163-71. PubMed ID: 22647890
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch
Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
[TBL] [Abstract][Full Text] [Related]
20. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.
Patel SB; Reams GP; Spear RM; Freeman RH; Villarreal D
Curr Hypertens Rep; 2008 Apr; 10(2):131-7. PubMed ID: 18474180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
